Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia

NCT01420926 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

165

Enrollment

NIH

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
Therapy-Related Acute Myeloid Leukemia

Interventions

DRUG: Bortezomib
DRUG: Decitabine
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

National Cancer Institute (NCI)